Dale Chappell - 27 Jul 2022 Form 4 Insider Report for HUMANIGEN, INC

Role
Chief Scientific Officer, Director, 10%+ Owner
Signature
/s/ Dale Chappell
Issuer symbol
N/A
Transactions as of
27 Jul 2022
Net transactions value
$0
Form type
4
Filing time
29 Jul 2022, 18:31:01 UTC
Previous filing
20 May 2022
Next filing
20 Oct 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HGEN Stock Option (Right to Buy) Award $0 +518,205 $0.000000 518,205 27 Jul 2022 Common Stock 518,205 $0.3800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in two equal installments on the first and second anniversaries of the grant date.